French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO).

Innovent Biologics (HKEX: 01801) has formed a strategic partnership with ASK Pharm (SZ: 002755) to commercialize limertinib, ...

UK-based AviadoBio, a LifeArc Ventures portfolio company, and Astellas Pharma today announced an exclusive option and license ...

Israel-based Teva Pharmaceutical Industries today announced that the US Food and Drug Administration (FDA) has accepted, and ...

Genor Biopharma (HKEX: 6998) is set to merge with Edding Group in a reverse takeover valued at 2.8 billion Yuan ($382 million ...

UK-based Mestag Therapeutics has entered a license and collaboration agreement with Merck & Co to explore new therapies for ...

China-headquartered clinical-stage biotech MediLink Therapeutics has announced a global clinical trial collaboration and ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Iqirvo (elafibranor), from French drugmaker ...

Japanese drugmaker Eisai has received approval in Thailand for Urece (dotinurad), a treatment for gout and hyperuricemia.

US antivirals specialist Gilead Sciences has released additional data from its pivotal Phase III PURPOSE 2 trial providing an ...

Germany’s Eckert & Ziegler has signed a global clinical supply agreement with Australian firm GlyTherix, providing GMP-grade ...

With its recent US Food and Drug Administration (FDA) approval, Eli Lilly’s Ebglyss (lebrikizumab) adds a new competitor to ...